Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human TLR7 Stable Cell Line

    [CAT#: S01YF-1023-PY213]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Immune Checkpoint Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    Immune Checkpoint
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;PANC-1
    Target Classification
    Immune Checkpoint Cell Lines
    Target Research Area
    immunology Research
    Related Diseases
    Systemic Lupus Erythematosus 17; Immunodeficiency 74, Covid19-Related, X-Linked
    Gene ID
    Human:51284
    UniProt ID
    Human:Q9NYK1

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    Toll-like receptor 7 (TLR7) is primarily known for recognizing single-stranded RNA, commonly found in viruses. Recent research has illuminated its role in various diseases, from viral infections to autoimmune disorders. For instance, enhanced TLR7 signaling has been linked to the aberrant survival of B cells, which can contribute to autoimmune diseases like systemic lupus erythematosus. Furthermore, TLR7's role in recognizing SARS-CoV-2, the virus responsible for COVID-19, has been highlighted, emphasizing its relevance in current global health challenges.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human TLR7 Stable Cell Line (S01YF-1023-PY213). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Jordan Davis (Verified Customer)

    How does TLR7 interact with viral RNA? Jun 10 2020

    chat Patrick Liam (Creative Biolabs Scientific Support)

    TLR7 can bind synthetic or viral RNA, suggesting that it may have immune functions mediated by viral RNA. This interaction indicates that red blood cells, expressing TLR7, could potentially be a reservoir for RNA-based diagnostics. Jun 10 2020

    chat Jordan Williams (Verified Customer)

    What is the role of TLR7 in immune response during influenza infection? Jan 14 2023

    chat Patrick Liam (Creative Biolabs Scientific Support)

    TLR7 plays a crucial role in activating the type I interferon response in lung epithelial cells during influenza A virus infection. The deletion of β6 integrin enhances TLR7-mediated immune response, indicating its importance in respiratory infections. Jan 14 2023

    Published Data

    Fig.1 The effective transduction of TLR7 and TLR8 in PANC 1 cells is depicted.

    Western blot analysis confirmed enhanced TLR7 and TLR8 protein expression in transduced PANC1 cells. As controls, PANC1 cells transduced with an empty vector were employed. As a control for protein loading, a β-actin control was employed.

    Ref: Grimmig, Tanja, et al. "TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer." International journal of oncology 47.3 (2015): 857-866.

    Pubmed: 26134824

    DOI: 10.3892/ijo.2015.3069

    Research Highlights

    Som, Avik. et al. "Percutaneous Intratumoral Immunoadjuvant Gel Increases The Abscopal Effect of Cryoablation for Checkpoint Inhibitor Resistant Cancer." Advanced healthcare materials, 2023.
    Percutaneous cryoablation is a commonly used medical technique for treating both metastatic and primary cancer. While there have been rare cases of this treatment causing a regression of distant metastases, known as the "abscopal" effect, its effectiveness is often limited. One potential solution is the use of intratumoral immunoadjuvants, though current options require frequent injections and lack the ability to confirm successful drug delivery. To address these challenges, a new injectable gel-based formulation called "Imigel" has been developed. This thermoresponsive gel contains the FDA-approved TLR7 agonist imiquimod and a contrast agent for visualization under CT. By using a specialized copolymer gel, this treatment offers improved drug concentration and release rate, requiring only one injection. Further testing has shown its ability to significantly enhance the abscopal effect of cryoablation in aggressive colorectal and breast cancer dual tumor models. In these studies, responders saw complete regression of bilateral tumors in 90 days.
    Som, Avik. et al. "Percutaneous Intratumoral Immunoadjuvant Gel Increases The Abscopal Effect of Cryoablation for Checkpoint Inhibitor Resistant Cancer." Advanced healthcare materials, 2023.
    Pubmed: 37870153   DOI: 10.1002/adhm.202301848

    Du, Yuxuan. et al. "Meta-analysis of the association between toll-like receptor gene polymorphisms and hepatitis C virus infection." Frontiers in microbiology, 2023.
    The aim of this study was to examine the potential correlation between hepatitis C virus (HCV) infection and the toll-like receptor (TLR) 3/7 gene polymorphisms.
    Du, Yuxuan. et al. "Meta-analysis of the association between toll-like receptor gene polymorphisms and hepatitis C virus infection." Frontiers in microbiology, 2023.
    Pubmed: 37869679   DOI: 10.3389/fmicb.2023.1254805

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare